ATE318581T1 - Sensibilisierung von roten blutkörperchen gegenüber ultraschall durch einwirkung eines elektrischen feldes - Google Patents

Sensibilisierung von roten blutkörperchen gegenüber ultraschall durch einwirkung eines elektrischen feldes

Info

Publication number
ATE318581T1
ATE318581T1 AT00948142T AT00948142T ATE318581T1 AT E318581 T1 ATE318581 T1 AT E318581T1 AT 00948142 T AT00948142 T AT 00948142T AT 00948142 T AT00948142 T AT 00948142T AT E318581 T1 ATE318581 T1 AT E318581T1
Authority
AT
Austria
Prior art keywords
red blood
ultrasound
sensitization
effect
blood cells
Prior art date
Application number
AT00948142T
Other languages
German (de)
English (en)
Inventor
Haro Ana Maria Rollan
Anthony Patrick Mchale
Roger Craig
Original Assignee
Uutech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uutech Ltd filed Critical Uutech Ltd
Application granted granted Critical
Publication of ATE318581T1 publication Critical patent/ATE318581T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A61K41/0033—Sonodynamic cancer therapy with sonochemically active agents or sonosensitizers, having their cytotoxic effects enhanced through application of ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00948142T 1999-07-23 2000-07-24 Sensibilisierung von roten blutkörperchen gegenüber ultraschall durch einwirkung eines elektrischen feldes ATE318581T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9917416.1A GB9917416D0 (enExample) 1999-07-23 1999-07-23
US14655699P 1999-07-30 1999-07-30

Publications (1)

Publication Number Publication Date
ATE318581T1 true ATE318581T1 (de) 2006-03-15

Family

ID=10857882

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00948142T ATE318581T1 (de) 1999-07-23 2000-07-24 Sensibilisierung von roten blutkörperchen gegenüber ultraschall durch einwirkung eines elektrischen feldes

Country Status (8)

Country Link
EP (1) EP1196143B1 (enExample)
JP (1) JP2003505409A (enExample)
AT (1) ATE318581T1 (enExample)
AU (1) AU6171000A (enExample)
CA (1) CA2378377A1 (enExample)
GB (1) GB9917416D0 (enExample)
MX (1) MXPA02000792A (enExample)
WO (1) WO2001007011A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0002856D0 (en) * 2000-02-08 2000-03-29 Gendel Limited Ultrasound sensitisation
AU2001272670A1 (en) * 2000-07-24 2002-02-05 Gendel Limited Polypeptide delivery II-2
EP1353723A2 (en) 2000-11-17 2003-10-22 Gendel Limited Ablation of cells using combined electric field and ultrasound therapy
US6821274B2 (en) 2001-03-07 2004-11-23 Gendel Ltd. Ultrasound therapy for selective cell ablation
JP4191998B2 (ja) * 2001-02-19 2008-12-03 ポーラ化成工業株式会社 エレクトロポレーション用の組成物
WO2003099382A1 (en) 2002-05-23 2003-12-04 Gendel Limited Ablation device
ES2708360T3 (es) 2013-12-20 2019-04-09 Hoffmann La Roche Compuestos que comprenden uno o más dominios hidrófobos y un dominio hidrófilo que comprende restos de PEG, útiles para unir células
WO2015091948A1 (en) 2013-12-20 2015-06-25 Roche Diagnostics Gmbh Method of immobilizing a cell on a support using compounds comprising a polyethylene glycol moiety
WO2015091953A1 (en) * 2013-12-20 2015-06-25 Roche Diagnostics Gmbh Use of compounds comprising two or more hydrophobic domains and a hydrophilic domain comprising peg moieties for stabilization of a cell
CN110090309B (zh) * 2019-05-28 2022-05-31 上海大学 功能基化红细胞膜的制备方法
CN113088494B (zh) * 2021-04-13 2022-08-05 武汉大学 一种用于释放被红细胞仿生材料捕获的肿瘤细胞的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2655801C2 (de) * 1976-12-09 1986-06-26 Kernforschungsanlage Jülich GmbH, 5170 Jülich Injizierbare Suspension von Membranvesikeln aus Erythrozyten und Verfahren zur Herstellung der Suspension
US4935223A (en) * 1988-08-04 1990-06-19 Board Of Regents, The University Of Texas System Labeled cells for use in imaging
US5236835A (en) * 1988-10-05 1993-08-17 Hapgood, C.V. Electro insertion of proteins into red cell membranes
JPH02121931A (ja) * 1988-10-29 1990-05-09 Res Inst For Prod Dev 濃縮ヘモグロビンの製造方法
AU725693B2 (en) * 1996-03-12 2000-10-19 Board Of Regents Of The University Of Nebraska, The Targeted site specific drug delivery compositions and method of use
EP0882448B1 (en) * 1997-05-05 2005-01-12 DIDECO S.r.l. Method of encapsulating biologically active agents within erythrocytes and apparatus therefor
DE19735460A1 (de) * 1997-08-16 1999-02-18 Rolf Prof Dr Med Zander Spül- oder Lagerungsflüssigkeit für Blutzellen

Also Published As

Publication number Publication date
WO2001007011A1 (en) 2001-02-01
GB9917416D0 (enExample) 1999-09-22
AU6171000A (en) 2001-02-13
EP1196143B1 (en) 2006-03-01
CA2378377A1 (en) 2001-02-01
EP1196143A1 (en) 2002-04-17
JP2003505409A (ja) 2003-02-12
MXPA02000792A (es) 2003-07-14

Similar Documents

Publication Publication Date Title
WO2005051483A3 (en) Electrical devices and anti-scarring agents
ATE318581T1 (de) Sensibilisierung von roten blutkörperchen gegenüber ultraschall durch einwirkung eines elektrischen feldes
PL375900A1 (en) Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer
DE59709437D1 (de) Neue phenanthridine
DE69837393D1 (de) Stimulierung von hämatopoietischen zellen im vitro
TR200100623T2 (tr) 5-Tia-w-ikameli fenil-prostaglandin türevleri, bunları üretme yöntemleri ve müessir madde olarak bunları ihtiva eden ilaçlar
AU2001269688A1 (en) Combination containing an antifolate and methylmalonic acid lowering agent
BR9801652A (pt) Resorcinil-triazinas
DE60025101D1 (de) Protonenleitendes Polymer, Herstellungsverfahren dafür, fester Polymerelektrolyt und Elektrode
DE60005670T8 (de) Aktualisierung der platzierung während der technologieabbildung
DE60101486D1 (de) Verwendung von Polyaminosäurederivate als Konservierungsmittel
WO2000018961A3 (en) Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
EP1154771A4 (en) INHIBITORS OF THE PROTON NITROSIS AND NITROSYL PUMP, COMPOSITIONS AND METHODS OF USE
EP1519755A4 (en) URTICANT CELLS EXPRESSING AN EXOGENOUS POLYNUCLEOTIDE THAT CODE FOR A THERAPEUTIC, DIAGNOSTIC OR COSMETIC AGENT, AND METHODS, COMPOSITIONS AND DEVICES USING THE USE OF SUCH CELLS OR CAPSULES DERIVED THEREFROM TO ADMINISTER THE THERAPEUTIC AGENT, DI
WO2006052658A3 (en) Methods and systems of cathodic protection for metallic enclosures
WO2004008286A3 (en) Arrangements and methods for treating a subject
BRPI0416637A (pt) método para produção de uma solução aquosa de etanolamina de cobre e de uma solução de monoetanolamina de cobre
MXPA06000652A (es) Sales alcalinas de inhibidores de bomba de protones.
WO2002040093A3 (en) Ablation of cells using combined electric field and ultrasound therapy
DE69800524D1 (de) Hermetisch abgedichtete Durchführung einer elektrischen Verbindung durch eine isolierende Wand, derwelche zwei Elektrodegruppen eines elektrochemischen Generators trennt
TR200202033T2 (tr) Epilepsi Tedavisi İçin Terkipler ve Yöntemler
DE50210630D1 (de) Verbinderteil eines elektrischen Steckverbinders
SI1196182T1 (sl) Postopek za povečanje zmogljivosti proizvodnje pri živali
ATE401107T1 (de) Intraduktale behandlung von brustläsionen umfassend therapeutische und diagnostische mittel
DE50004906D1 (de) Datenübermittlung zwischen Modulen eines elektrischen Geräts

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties